We are live on ! Find out more
SFM

Sphera Funds Management Portfolio holdings

AUM $630M
1-Year Est. Return 108.65%
This Fund
S&P 500
This Quarter Est. Return
-19.99%
1 Year Est. Return
+108.65%
3 Year Est. Return
+217.64%
5 Year Est. Return
+342.91%
10 Year Est. Return
+2,254.45%
AUM
$887M
AUM Growth
+$16.2M
Cap. Flow
+$129M
Cap. Flow %
14.54%
Top 10 Hldgs %
50.79%
Holding
136
New
23
Increased
31
Reduced
31
Closed
36

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$34.3M
2
AZN icon
AstraZeneca
AZN
+$20.1M
3
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$14.8M
4
VTRS icon
Viatris
VTRS
+$11.4M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$10.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$44.9M
2
MRK icon
Merck
MRK
+$22.8M
3
GSK icon
GSK
GSK
+$21.9M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$8.53M
5
V icon
Visa
V
+$6.06M

Sector Composition

Rank Sector Weight
1 Healthcare 60.28%
2 Technology 12.21%
3 Industrials 2.92%
4 Consumer Discretionary 0.53%
5 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABUS icon
101
Arbutus Biopharma
ABUS
$857M
– –
-40,000
Closed -$378K
ALNY icon
102
Alnylam Pharmaceuticals
ALNY
$27.5B
– –
-40,000
Closed -$3.5M
AQST icon
103
Aquestive Therapeutics
AQST
$464M
– –
-95,300
Closed -$1.67M
ASMB icon
104
Assembly Biosciences
ASMB
$498M
– –
-8,369
Closed -$3.73M
AUDC icon
105
AudioCodes
AUDC
$244M
– –
-59,226
Closed -$596K
BMRN icon
106
BioMarin Pharmaceuticals
BMRN
$11.6B
– –
-88,000
Closed -$8.53M
CARM
107
DELISTED
Carisma Therapeutics
CARM
– –
-31,500
Closed -$1.35M
CHTR icon
108
Charter Communications
CHTR
$17.3B
– –
-1,419
Closed -$462K
CMCSA icon
109
Comcast
CMCSA
$85B
– –
-5,993
Closed -$212K
CSCO icon
110
Cisco
CSCO
$457B
– –
-100,000
Closed -$4.87M
FLEX icon
111
Flex
FLEX
$41.7B
– –
-211,722
Closed -$2.09M
GOOGL icon
112
Alphabet (Google) Class A
GOOGL
$4.36T
– –
-65,380
Closed -$3.95M
IFF icon
113
International Flavors & Fragrances
IFF
$20.2B
– –
-36,450
Closed -$5.07M
JNJ icon
114
Johnson & Johnson
JNJ
$618B
– –
-325,000
Closed -$44.9M
LOW icon
115
Lowe's Companies
LOW
$117B
– –
-2,500
Closed -$287K
CYPH
116
Cypherpunk Technologies Inc
CYPH
$62.9M
– –
-33,253
Closed -$2.59M
MA icon
117
Mastercard
MA
$502B
– –
-22,760
Closed -$5.07M
ORLY icon
118
O'Reilly Automotive
ORLY
$72.9B
– –
-162,660
Closed -$3.77M
RDWR icon
119
Radware
RDWR
$1.1B
– –
-17,527
Closed -$464K
SEDG icon
120
SolarEdge
SEDG
$2.51B
– –
-150,817
Closed -$5.68M
SITE icon
121
SiteOne Landscape Supply
SITE
$4.12B
– –
-3,000
Closed -$226K
SNA icon
122
Snap-on
SNA
$21.2B
– –
-21,666
Closed -$3.98M
UNH icon
123
UnitedHealth
UNH
$376B
– –
-2,000
Closed -$532K
V icon
124
Visa
V
$684B
– –
-40,401
Closed -$6.06M
VKTX icon
125
CALL
Viking Therapeutics
VKTX
$3.7B
– –
-23,900
Closed -$416K
2 3 4
5
6

Similar funds

VIM
Vancity Investment Management Vancouver, British Columbia, Canada $629M AUM 2.49% 1-Year Est. Return
KCMH
Keywise Capital Management (HK) Hong Kong $630M AUM 81.01% 1-Year Est. Return
FCFC
First Commonwealth Financial Corp Indiana, Pennsylvania $629M AUM 20.47% 1-Year Est. Return
BI
BlueSpruce Investments Chicago, Illinois $631M AUM 11.83% 1-Year Est. Return
PWW
Pettyjohn Wood & White Lynchburg, Virginia $628M AUM 20.96% 1-Year Est. Return
TTSTC
Texas Treasury Safekeeping Trust Company Austin, Texas $628M AUM 15.58% 1-Year Est. Return
SWP
Summit Wealth Partners Orlando, Florida $632M AUM 9.71% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return

Sphera Funds Management's Q4 2018 Portfolio in Review

As of Q4 2018, Sphera Funds Management held 136 positions worth $887M, up 1.9% from $871M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sphera Funds Management deployed $129M of net new capital in Q4 2018, opening 23 new positions and adding to 31 existing holdings. Its largest new stake was Celgene Corp: 465,000 shares worth $29.8M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, down from 75% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Merck, an estimated $22.8M trimmed.

  • Sphera Funds Management's largest Q4 2018 buy was Celgene Corp: 465,000 shares worth $29.8M.
  • Sphera Funds Management added most to Viatris in Q4 2018, an estimated $11.4M increase.
  • Sphera Funds Management's biggest Q4 2018 reduction was Merck, cutting an estimated $22.8M.
  • Sphera Funds Management fully exited Johnson & Johnson in Q4 2018, selling an estimated $44.9M.
  • Sphera Funds Management's ten largest holdings make up 51% of its $887M portfolio in Q4 2018.
  • Sphera Funds Management opened 23 new positions and closed 36 in Q4 2018.
  • Sphera Funds Management's portfolio value rose 1.9% quarter-over-quarter to $887M.

Based on Sphera Funds Management's 13F filing for Q4 2018, filed 14 Feb 2019.